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V. Meikle,1* A. Alito,1 A. S. Llera,2 A. Gioffré,1 A. Peralta,1 B. M. Buddle,3 and A. Cataldi1
Institute of Biotechnology, INTA, Castelar, Argentina1; Fundación Instituto Leloir, Buenos Aires, Argentina2; and AgResearch,
Hopkirk Research Institute, Palmerston North, New Zealand3
Received 21 May 2009/Returned for modification 16 June 2009/Accepted 21 July 2009
Culture filtrate and cell extracts from Mycobacterium bovis cultures contain molecules which could promote
protective immunity to tuberculosis in animals. Different protein fractions of M. bovis cultures were obtained
by elution electrophoresis and were tested in experimentally infected cattle. The fractions that elicited gamma
interferon (IFN-) responses were resolved by two-dimensional gel electrophoresis, and individual proteins
were identified by matrix-assisted laser desorption ionization–time of flight mass spectrometry. The open
reading frames were cloned, expressed as their recombinant forms, and retested with naturally and experi-
mentally infected animals. Eleven protein fractions were highly reactive, from which the Rv1636, HspX,
Rv0138, Rv2524, EsxI, and Rv3740 recombinant proteins were obtained. EsxI and HspX were the antigens most
recognized by the IFN- release assay. In summary, a proteomic approach allowed the identification of novel
antigens useful for the diagnosis of bovine tuberculosis.
Infection and disease with Mycobacterium bovis, the caus-
ative organism of bovine tuberculosis (TB), is an important
health problem in cattle and other animal species. The disease
presents a major barrier to animal-related trade and produc-
tion, causing significant losses to farming economies world-
wide. Furthermore, bovine TB has serious zoonotic implica-
tions, especially in developing regions. In North and South
America, there are 420 million cattle, half of which are in
countries with an incidence of bovine TB higher than 1% (13).
The disease control programs carried out in most countries are
based on a test and removal strategy utilizing the tuberculin
skin test (TST) with purified protein derivative (PPD) (4).
Accurate detection using the TST and removal of infected
cattle form the base of control strategies for bovine TB. It is
widely recognized that tests for cell-mediated immunity are far
more sensitive than antibody tests in detecting bovine TB (38).
Disease control based on the use of PPD can be facilitated by
using the gamma interferon (IFN-) test for bovine TB (39).
The PPDs are obtained by acid precipitation from heat-killed
cultures of M. bovis (PPD-B) and Mycobacterium avium
(PPD-A) and are poorly defined (27), containing many pro-
teins, lipids, and sugars. Many of these compounds are shared
by different mycobacterial species or even with other bacteria
(22). The detection of false positives has been a significant part
of the economic cost, particularly in areas where there is a
relatively low incidence of the disease (28), and thus, there is
an urgent need for more specific reagents for the diagnosis of
M. bovis infection.
Many mycobacterial proteins have been isolated, and bovine
T-cell epitopes have been characterized for several of them (2,
9, 26, 30, 32). Immunodominant peptides from M. tuberculosis
Rv3873, Rv3879c, Rv3019c, Rv0288, ESAT-6, and CFP-10
genes were described as good T-cell inducers, and the diag-
nostic potential of a cocktail composed of these dominant
peptides was demonstrated using naturally infected field ani-
mals (10). The Rv3615c epitope in combination with a previ-
ously described differential test based on ESAT-6 and CFP-10
has the potential to significantly increase diagnostic sensitivity
without reducing specificity in M. bovis BCG-vaccinated pop-
ulations (34). Other mycobacterial antigens (TPX, TRB-B,
Rv3747, and L7/L12) were reported to have induced high stim-
ulation indices in M. bovis-infected animals with the IFN-
assay (3). Our group has previously participated in a multi-
laboratory study that assessed the sensitivity and specificity of
the IFN- test using several antigens in cattle naturally in-
fected with M. bovis. When the skin test-positive and -negative
groups were compared, the recombinant antigens (ESAT-6,
CFP-10, and PE13) which induced the highest levels of IFN-
release in the cattle examined were all able to differentiate the
positive and negative Argentinean groups (1). IFN- tests uti-
lizing specific mycobacterial antigens have the advantage of
enhanced specificity compared to that of the PPD-based IFN-
test, but currently, the sensitivity of these tests needs to be
improved. To improve the sensitivity, additional immunoreac-
tive mycobacterial antigens need to be identified and added to
a pool of the most reactive and specific mycobacterial antigens.
The aim of this work was to identify additional antigens
through a screening of native protein fractions from a culture
of M. bovis AN5. For this objective, we used blood from cattle
experimentally infected with M. bovis to select native fractions
as a source of antigens in IFN- tests. The selected antigenic
fractions were further separated into individual proteins by
two-dimensional (2D) gel electrophoresis (2D-E), and the
spots were identified by matrix-assisted laser desorption ion-
ization–time of flight mass spectrometry (MALDI-TOF MS).
Through this approach, we could recognize novel proteins with
diagnostic potential.
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Bacterial cultures and sample preparation. The M. bovis AN5 strain was used
throughout the study. Mycobacterial cultures were grown as described previously
(3). Cultures were prepared in Middlebrook 7H9 (BD, United States) liquid
medium containing 0.4% pyruvic acid and 0.4% glucose. Mycobacterial cultures
were incubated at 37°C and harvested at 21 days. To obtain the culture filtrate,
the supernatant was separated from the cell extract by centrifugation for 30 min
at 7,000  g and then filtered using a 0.2-m filter (Millipore). The proteins were
precipitated with 50% ammonium sulfate for 18 h at 4°C. Following centrifuga-
tion at 10,000  g for 1 h, the precipitate was dissolved in a minimal volume of
phosphate-buffered saline (PBS) and then dialyzed against PBS for 18 h at 4°C.
To obtain the cell extract, the culture supernatant was removed and the cell mass
washed and resuspended in PBS. Mycobacteria were killed by heating for 40 min
at 80°C, followed by sonication (Branson Sonifier 250) on ice five times for 1 min
with rest intervals of 2 min. The protein contents of the supernatants and cell
extracts were quantified by the bicinchonic acid method (Pierce, Rockford, IL).
Molecular mass fractions of CSF and cell extract. Proteins were divided into
narrow molecular mass fractions by continuous elution of polyacrylamide gels as
described previously (27). In brief, culture supernatant filtrate (CSF) and cell extract
(5 mg of protein) were resolved by sodium dodecyl sulfate-polyacrylamide gel elec-
trophoresis (SDS-PAGE). Antigen preparations resuspended in loading buffer (2%
SDS, 0.125 M Tris HCl, pH 6.8, 1% 2-mercaptoethanol, 0.02% bromophenol blue,
10% glycerol) were heated for 4 min in boiling water. Thirty fractions were collected
using a whole-gel elutor (Bio-Rad). The protein concentration of the different
fractions was estimated by the micro-bicinchoninic acid method. The 30 fractions
were pooled according to their molecular weights, and they were dialyzed against
PBS. We obtained 15 fractions from the cell extract (1E to 15E, in decreasing order
of molecular mass) and 13 fractions from the CSF (1S to 13S), and all were kept
frozen at 80°C until used.
2D-E. Protein separation by 2D-E was performed as described previously (18),
with some modifications. Briefly, samples of cell extract or CSF ranging from 0.2
to 15 g of protein were diluted in an appropriate volume of rehydration solution
{7 M urea, 2 M thiourea, 2% 3-[(3-cholamidopropyl)-dimethylammonio]-1-pro-
panesulfonate [CHAPS], 0.5% immobilized pH gradient [IPG] buffer, pH 3 to
10, 50 mM dithiothreitol} and incubated with shaking for 1 h at room temper-
ature. Samples were applied by cup loading into rehydrated 11-cm IPG strips, pH
3 to 10 (GE Healthcare, Piscataway, NJ). Isoelectric focusing (IEF) was per-
formed in an Ettan IPGphor IEF system (GE Healthcare, Piscataway, NJ). After
IEF, strips were incubated for 20 min in equilibration buffer (50 mM Tris-HCl,
pH 8, 6 M urea, 30% glycerol [vol/vol], 2% SDS, 0.005% bromophenol blue)
containing 1% dithiothreitol, followed by a second 20-min incubation with 4%
iodoacetamide in equilibration buffer. SDS-PAGE was performed on 10% poly-
acrylamide gels using a Mini Protean 3 system (Bio-Rad, Hercules, CA). IPG
strip ends were clipped to fit gel width and loaded onto 8- by 7.3-cm SDS-
polyacrylamide gels (100V for 1 h). After the gels were run, the proteins were
detected using MS-compatible silver staining (20).
MALDI-TOF MS. MS identification of 2D spots was performed with MALDI-
TOF MS as a paid service by the Institut de Biotecnologia i Biomedicina,
Universitat Autónoma de Barcelona, Barcelona, Spain. Proteins were identified
from spectrometry data by using the MSFit (http://prospector.ucsf.edu
/prospector/mshome.htm) on-line services.
Expression and purification of M. bovis Rv1636, HspX, Rv0138, Rv2524, EsxI,
and Rv3740. Gene sequences for the mature Rv1636, HspX, Rv0138, EsxI, and
Rv3740 proteins were amplified by PCR using primers based on published
sequences from M. tuberculosis H37Rv (Table 1). The Rv2524 gene, encoding a
fatty acid synthase, is large in size, and in consequence, only a portion of the
gene, corresponding to the fragment detected by MALDI, was cloned. Two
restriction enzyme sites were introduced into primers to facilitate subsequent
cloning in frame into the expression vector pRSET-A (Invitrogen BV, Leek, The
Netherlands). Digested PCR products were ligated to pRSET-A. The pRSET-
derived constructions were used to transform Escherichia coli BL21(DE3) com-
petent cells. An inoculum (3 ml grown in LB-ampicillin for 16 h at 37°C) of E.
coli BL21 harboring pRSET-A with Rv1636, HspX, Rv0138, Rv2524, EsxI, or
Rv3740 gene inserts was diluted to an initial optical density (OD) at 650 nm of
0.01 and grown to the mid-logarithmic growth phase. A 0.5 mM concentration of
isopropyl--D-thiogalactopyranoside (IPTG) was added to induce recombinant-
gene expression over 3 h. Cells were then harvested by centrifugation and frozen
at 20°C until further use. The cell pellet was lysed with 1 ml of lysis buffer (1
M Tris–HCl, pH 7.5) using a FastPrep FP120 (Bio101-Savant, Holbrook, NY).
The expression of antigens was confirmed both by analysis of Coomassie blue-
stained polyacrylamide gels and Western blot analysis using anti-His antibodies
(GE Healthcare). The recombinant protein in the E. coli cell extract was purified
by using a Pro-Bond resin column with immobilized nickel (Invitrogen Corp.,
CA) and eluted with increasing concentrations of 50 mM to 500 mM imidazole
(Sigma, St. Louis, MO).
Experimentally infected animals. Animal experimentation was performed in-
side INTA’s biosecurity box facilities in compliance with regulations set by the
Ethical Committees of the European Union and New Zealand. To test the
different fractions, four castrated male Friesian cattle 6 months of age were
obtained from herds with no history of M. bovis infection for at least 6 years.
These animals were confirmed as bovine TB negative by in vitro testing of T-cell
responses to mycobacterial antigens as determined by using a IFN- test. During
the study, these animals were housed in isolation. They were infected by intra-
nasal instillation of 106 CFU of M. bovis AN5 using previously described methods
(27). Two animals of the same age and origin were used as uninfected controls.
Before inoculation, blood samples were taken from the jugular vein and the
IFN- assay was performed in all animals to set a control point. At different times
after experimental infection, blood samples were collected from the jugular vein
in heparinized vials to be used to test the antigenicity of protein fractions in the
IFN- blood test (Bovigam; Pfizer Animal Health Ltd., Melbourne, Australia).
Eight months after experimental infection, the animals were skin tested using the
single intradermal comparative tuberculin test. The four experimentally infected
animals were PPD positive, while the two uninfected controls remained negative.
One year after experimental infection, the animals were slaughtered and nec-
ropsies were performed. A postmortem inspection of lymph nodes, liver, and
lungs was performed. Samples of the tissues mentioned were taken, and M. bovis
infection was confirmed by bacterial culture.
A second experimental inoculation study was carried out in order to evaluate
immunoreactivity to the recombinant antigens. Ten calves were inoculated in-
tratracheally with 103 CFU of M. bovis (strain WAg201) as described previously
(36). All animals were positive in the single intradermal comparative tuberculin
test at 14 weeks after challenge. Blood samples were taken at 16 weeks after
challenge, and all cattle were necropsied 17 weeks after challenge. Samples from
four thoracic lymph nodes (the left and right bronchial lymph nodes, as well as
the anterior and posterior mediastinal ones) were collected from all of the
animals for bacterial culture and histology. Additional samples were collected
from all tuberculous lesions observed in the lungs, other lymph nodes, or organs.
Procedures for the identification of macroscopic tuberculous lesions and pro-
TABLE 1. PCR primers used for cloning of Rv1636, Rv0138, Rv2524, esxI, Rv3740, and hspX
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cessing for histopathology and bacterial counts have been described previously
(36). Gross tuberculous lesions were observed in thoracic lymph nodes of all of
the animals and in the lungs of 7 of the 10. M. bovis was isolated from lymph node
samples from all of the animals.
Naturally infected animals. To test the performance of recombinant antigens
in naturally infected cattle, five dairy herds suspected of containing tuberculous
animals (n  79) and one TB-negative dairy herd (n  22) were selected. The
herds were located in different regions of Argentina, at least 200 km apart. The
animals were skin tested using the single intradermal comparative tuberculin
test. The 79 animals from the infected herds were all skin test positive, while the
22 animals from the negative herd were skin test negative. Blood samples were
collected from the jugular vein into heparinized vials.
IFN- blood test. A commercial bovine IFN- microplate enzyme-linked im-
munosorbent assay kit (Bovigam; Pfizer Animal Health Ltd., Melbourne, Aus-
tralia) was used according to the manufacturer’s instructions to measure the
T-cell responses in whole-blood cultures after 16 h of in vitro stimulation with
various antigens (PPD-A, PPD-B, protein fractions, or the recombinant anti-
gens). Briefly, aliquots of 200 l of blood were added in duplicate to wells in a
96-well microplate for culture with antigens in duplicate. The optimal antigen
concentrations were determined by comparing the area-under-the-curve values
obtained by compound symmetry analysis at eight dilution points for TB-infected
and TB-free animals (1), and the final concentration was set at 4 g/ml for all
antigens tested, except for PPD-A and PPD-B, which were used at a final
concentration of 20 g/ml. Negative-control wells, to which only PBS was added,
were included for each animal tested, as well as positive controls containing 1
g/ml pokeweed mitogen (Sigma-Aldrich, United Kingdom). PPD-A, PPD-B,
and an ESAT-6/CFP-10 combination were included as reference antigens. Blood
and antigens were incubated in a humidified 5% CO2 incubator at 37°C for 16 h.
Culture supernatants were pooled before the measurement of IFN- release by
enzyme-linked immunosorbent assay. The OD for the PBS controls, which was
usually approximately 0.1 OD units, was used to normalize individual readouts
and to calculate OD indices (ODIs), where the results obtained by antigen
stimulation were divided by the results for the PBS-stimulated cultures.
Polyclonal antibody production against recombinant antigens. Two BALB/c
mice for each antigen were inoculated intraperitoneally with purified recombi-
nant antigen. They received two immunizations with 4 g of each antigen in
incomplete Freund’s adjuvant (Sigma, United Kingdom) at days 1 and 8. At day
20, sera were obtained and the recognition of the specific protein was confirmed
by Western blot analysis. Anti-His6 antibody (GE Healthcare) was used as a
control in order to locate the band.
Western blot analysis. Mycobacterial proteins were separated on SDS–12%
polyacrylamide gels and transferred to nitrocellulose membrane (GE Health-
care). Blots were blocked with 5% nonfat dried milk–0.1% Tween 20 (vol/vol) in
Tris-buffered saline (T-TBS), washed with T-TBS, and probed with mouse-
specific polyclonal antibody at a 1:100 dilution. Alkaline phosphatase-conjugated
anti-mouse immunoglobulin G (Sigma) was used at a dilution of 1:2,000. To
evaluate the recognition of the recombinant antigens by the bovine sera, a 1:100
dilution of sera in 5% nonfat dried milk–T-TBS was employed. As a secondary
antibody, alkaline phosphatase-conjugated anti-bovine immunoglobulin G
(Sigma) was used at a dilution of 1:30,000. For detection, 5-bromo-4-chloro-3-
indolylphosphate (BCIP)/nitroblue tetrazolium color development substrates
(Promega, Madison, WI) were used.
Statistical analysis. ODI values were modeled as dependent on the time
postinfection, the fraction (supernatant or extracellular), and their interaction.
The ODI measurements were undertaken on the same animal over time. A total
of four animals were used in this assay. The animal effect was included as a
random effect, creating a compose-symmetry structure of the correlation for the
same fraction over time. The residual variance was also modeled as dependent
on time because of the presence of heteroscedasticity. The model was estimated
with the lme function of the nlme library of the R package, using InfoStat. The
results of the post hoc test of mean difference were assessed by the Di Rienzo-
Gnzman-Casa Moves procedure (35).
RESULTS
Separation of protein fractions by electroelution (SDS-
PAGE) and evaluation by IFN- release tests in blood from
experimentally infected animals. Thirty protein fractions were
obtained in various concentrations from 17 to 80 g/ml and
with molecular masses ranging from 7 to 208 kDa in a 12.5%-
SDS–PAGE, as shown in the supplemental figure. Pairs of
consecutive fractions were pooled, and these were used to test
blood from experimentally infected cattle in IFN- release
tests. Blood was collected at 17, 40, and 156 days postinfection
(dpi). We observed that, in general, fractions from culture
supernatant were more antigenic than those from cell extract
(Fig. 1). In both the culture supernatant and cell extract, the
lower-molecular-mass fractions were more antigenic. We also
observed that at longer times postinfection, the response was
stronger for most fractions.
Supernatant fraction. For the supernatant fraction, the re-
lationship between time postinfection and level of IFN- re-
leased was significant (P 	 0.0001), indicating that ODI means
differed between fractions depending on the evaluation time
point (Fig. 1A). There were three levels of ODI: level “a,” low
(ODI 	 4.1); level “b,” intermediate (ODI 4.1 to 8.2); and
level “c,” high (ODI 
 8.2), corresponding to significant dif-
ferences among ODI means between the different fractions.
Combinations of supernatant fractions and times postinfection
are identified in Fig. 1A with the appropriate label indicating
their level.
Supernatant fractions 1, 3, 4, 5, and 7 remained at level “a”
during all times in the evaluation. These fractions had statis-
tically similar ODI means irrespective of whether the compar-
ison was between or within the fractions. Fraction 6 showed a
significant increase at 40 dpi, reaching level “b.” At 17 and 156
dpi, its level was “a.” Fractions 2, 8, and 9 showed significant
increases at the end of the evaluation period (156 dpi), reach-
ing level “b.” Fractions 11 and 13 had initial values correspond-
ing to level “a” but then increased to level “b” for the last two
evaluation times. Fractions 10 and 12 increased their ODI
values according to the time postinfection; they began at level
“a” and ended up at level “c.” These fractions had ODI levels
higher than the PPD-B or ESAT-6/CFP-10 values at 156 dpi.
Cell extract fraction. The comparison of cell extract frac-
tions by time relationship was significant (P 	 0.0209), indi-
cating that the ODI means differed between fractions depend-
ing on the evaluation time point. The level “a” ODI (	2), level
“b” ODI (2 to 4.5), and level “c” ODI (
4.5) corresponded to
significant differences. The results are summarized in Fig. 1B.
Cell extract fractions 1, 2, 3, 4, 6, 8, 10, and 11 remained at
level “a” during all of the evaluation times. These fractions had
statistically similar ODI means irrespective of whether the
comparison was between or within the fractions. Fractions 7, 9,
13, 14, and 15 showed significant increases at 40 dpi, reaching
level “b.” Fractions 5 and 12 showed significant increases at the
end of the evaluation period (156 dpi), reaching level “b,”
whereas fractions 13, 14, and 15 showed significant increases at
both 40 and 156 dpi. None of the fractions reached a IFN-
level as high as that of PPD-B or the ESAT-6/CFP-10 combi-
nation at the corresponding times.
When naturally infected animals were tested with these frac-
tions, a pattern similar to that seen for the experimentally
infected cattle was observed, in that there were stronger re-
sponses for the culture supernatant antigens and higher anti-
genicity of low-molecular-weight fractions (data not shown).
Analysis of M. bovis fractions by preparative 2D-E. Those
fractions with high ODIs and enough protein concentration to
perform the technique were selected for preparative 2D-E.
Individual proteins from the selected fractions (2S, 8S, 12E,
and 13E) were separated by using 2D-E with IEF as the first
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step, followed by separation according to size in SDS-PAGE
gels. Between two and four spots were identified in each frac-
tion (Fig. 2), excised, and submitted to MALDI-TOF MS.
Identification and characterization of selected proteins. The
proteins identified by MS and bioinformatics screening of My-
cobacterium tuberculosis complex genomes are listed in Table
2. In the cell extract fractions, Rv1636, HspX, and Rv0138
were identified, while Rv3740, EsxI, and a fragment of FasI
were identified in the culture supernatant fractions. No signal
sequences were observed in the primary sequences of the pro-
teins found in the cell extract (data not shown). On the other
hand, the presence of signal sequences in the culture superna-
tant proteins was varied. Rv3740 is the largest protein identi-
fied and shows an N-terminal sequence compatible with a
signal sequence. EsxI belongs to the Esx protein family; EsxA,
the founding member of the family, has no signal sequence and
is secreted by an ad hoc secretion system (17). FasI (326 kDa)
is the central enzyme in fatty acid synthesis and reportedly
cytoplasmic. The finding of a fragment of FasI in culture su-
pernatants may indicate cell lysis with subsequent proteolysis.
Expression and purification of recombinant mycobacterial
proteins. The genes corresponding to the antigens selected,
Rv1636, Rv0138, EsxI, HspX, Rv3740, and a fragment of
Rv2524 (Table 2), were amplified by PCR and cloned in the
FIG. 1. Results of IFN- whole-blood-based assay against the culture supernatant fractions (A) and cell extract fractions (B) in four cattle
following intranasal infection with M. bovis. Reference and recombinant antigen results are also shown. Results are expressed as the ODI for each
time point of blood extraction. There were three levels of ODI, “a,” “b,” and “c,” corresponding to significant differences among ODI means. Error
bars show standard deviations.
FIG. 2. Selection of spots in the 2D gels. Gels were stained with silver nitrate. Arrows indicate selected spots.
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pRSET-A expression vector in order to create a fusion to an
N-terminal histidine tag. They were expressed in E. coli BL21
and purified under native conditions. As Rv2524c is a very
large fatty acid synthase protein, we decided to clone just the
15-kDa fragment that comprised the region detected by
MALDI-TOF MS. The levels of expression of recombinant
proteins were determined both by analysis of Coomassie blue-
stained polyacrylamide gels and Western blot analysis using
antihistidine antibody (data not shown).
Localization. To determine the cellular localization of the
antigens, specific sera obtained from mice were used in West-
ern blot assays. EsxI was detected in the M. bovis (AN5) cul-
ture supernatant, while HspX was detected in the cell extract
(Fig. 3). At the same time, Rv1636 and Rv0138 were localized
in the cell extract, whereas Rv3740 and Rv2524c were detected
in the culture supernatant, as expected (data not shown). All
the proteins showed apparent molecular masses in SDS-PAGE
that were expected from sequence analysis.
Recombinant antigen recognition in experimentally infected
animals. To further assess the antigenicity of the protein an-
tigens identified herein, blood samples were collected from 10
experimentally infected animals. PPD-B and a combination of
ESAT-6 and CFP-10 showed high ODIs in the IFN- test for
all animals at 114 dpi. The average reactivity of EsxI was 26.6
and that of Rv0138 was 11.1 for the ODI. The reference anti-
gens PPD-B and ESAT-6/CFP-10 had average values of 42 and
46 ODI, respectively (Fig. 4). Nine of 10 animals responded to
EsxI, whereas 7 of 10 animals responded to Rv0138, based on
an arbitrary ODI of 2.0 used as the cutoff. M. bovis infection
was confirmed in all animals based upon the presence of tu-
berculous lesions and culture of M. bovis (data not shown).
Recombinant antigen recognition in naturally infected ani-
mals. To assess cell-mediated immune responses toward my-
cobacterial antigens in skin test-positive and -negative animals,
blood samples were obtained from 79 skin test reactors from
different herds (naturally infected animals) and 22 nonreactor
cattle in TB-free herds. The six recombinant proteins, along
with PPD-B (average ODI, 6.2) and PPD-A (average ODI,
2.4), were screened against samples from skin test-positive
animals (Fig. 5). Based on the average of the IFN- responses,
HspX (average ODI, 3.85) and EsxI (average ODI, 2.75) were
the most antigenic of this set of novel antigens. The average
ODI values for novel and reference antigens in TB-free herds
were very low (1.15 for EsxI, 1.35 for HspX, 1.35 for PPD-B,
and 1.25 for PPD-A). The other proteins did not show a sig-
nificant level of immune reactivity in either group of animals.
DISCUSSION
The resolution of cell extract and culture supernatant pro-
teins from several molecular weight fractions of M. bovis and
the study of their immune cellular reactivities following an
experimental infection have allowed us to identify various
trends in immune response patterns. As observed by other
TABLE 2. Characteristics of selected proteins









TB15.3 Rv1636, Mb1662 12E 15.31 95 88 55 Unknown
HspX Rv2031c, Mb2057c 12E 16 59 78 72 Stress protein induced by
anoxia (11, 14)
Rv3740 Rv3740c, Mb3766c 2S 48 78 76 78 Unknown
FasI (fragment) Rv2524c, Mb2553c 8S 15 86 90 69 Lipid synthesis (15)
EsxI Rv1037c, Mb1066c 8S 10 91 0 79 Unknown
Rv0138 Rv0138, Mb0143 13E 19 86 86 64 Unknown
FIG. 3. EsxI and HspX detection by Western blot analysis in CSF
or cell extract of M. bovis AN5 culture. EsxI- and HspX-specific mouse
antibodies were used for detection in blotted CFS and cell extract
proteins.
FIG. 4. Results of IFN- whole-blood-based assay against recom-
binant antigens in 10 cattle experimentally infected with M. bovis.
Results are expressed as the scatter plot of the ODIs. ODIs (points)
and means (horizontal bars) are shown. The IFN- data are for sam-
ples obtained at 114 dpi. Error bars show standard deviations.
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authors (6), proteins from the culture supernatant, were in
general, more reactive than those from the cell extract. In fact,
many of the more strongly reacting antigens (Ag85 complex,
ESAT-6, CFP-10, MPB70, MPB83, P38, etc.) of M. tuberculosis
complex proteins are found in the supernatant (7, 8, 24, 27, 29,
33, 37).
The low-molecular-weight fractions (fractions 10 and
greater) appeared to be more antigenic, especially those from
the culture supernatant. It is possible that low-molecular-
weight fractions are enriched in peptides resulting from the
degradation of larger proteins. Bassey et al. (6) observed a
predominance of low-molecular-weight fractions with immune
reactivity when working with cell extracts. This observation
could not be attributed only to the presence of strong antigens,
such ESAT-6 and CFP-10, in low-molecular-weight fractions,
because their predominance was also observed when the frac-
tion were prepared from M. bovis BCG, where these antigens
are absent. A similar predominance was reported by Lamb and
Young (21), working with cell extracts. The possible explana-
tions for this predominance of high reactivity in low-molecular-
weight fractions have been discussed by Bassey et al. (6). One
exception to this consistent pattern of predominance was the
results of Gulle et al. (19). However, it must be noted that they
inoculated animals with BCG and not with a virulent strain,
although they did discriminate between the responses to cul-
ture filtrate and cell extracts.
We have also observed that in most cases, the reactivities of
fractions increased with time postinfection for both the cell
extract and culture supernatant fractions. This observation is in
contrast to that of Aagaard et al. (2) using recombinant pro-
teins. They observed that the level of IFN- decreased at the
late stages of infection. Conversely and in concurrence with
our observations, Fifis et al. (16), working with very late time
points postinfection (27 months postinoculation) and native
purified antigens, observed an increase of reactivity with time,
although it was dependent on antigens and individual animals.
At present, it is difficult to identify the reason for these differ-
ences.
Another common finding shared with other researchers was
the high variability of the immune response at the individual
level. This variability may reflect the polymorphism in the
major histocompatibility complex genes (BoLA) of individual
cattle.
Although we obtained 30 different fractions, not all of them
reached the minimal concentration required for 2D-E analysis.
This was the main reason for choosing just some of the pooled
fractions.
2D-E identified different proteins in the fractions studied.
The numbers of spots were reduced (two to four) compared to
the numbers theoretically expected. The low resolution of 2D
gel or the method of protein detection may have influenced
this result. In addition, some spots could not be identified by
MS (data not shown). This opens the possibility that some
spots which were not identified by MS could be immunoreac-
tive. One of the antigens identified, HspX (Rv2031c), also
known as Acr, or 16-kDa protein, has been previously de-
scribed. It is a stress protein induced by hypoxic culture con-
ditions. Other evidence (11, 14, 23, 31) has led to the propo-
sition that HspX has a central role in the viability of the bacilli
during latent, asymptomatic infections in humans and in a
mouse model of TB. In contrast, its role in bovine TB has been
not studied. The other proteins have been reported as diag-
nostic antigens; Rv1636 has been indicated as a cell wall pro-
tein (5, 25, 32). There are no previous reports of Rv0138 as an
antigen. Rv3740 has been postulated to be a possible triacyl-
glycerol synthase (diacylglycerol acyltransferase), involved in
the initiation of dormancy (12). EsxI is a member of the Esx
protein family (17), all of which are secreted and of low mo-
lecular weight. The founding member of this group is EsxA
(ESAT-6). In spite of being a member of this important family
of antigens, there are no previous reports about its antigenicity.
A special case is that of Rv2524, or Fas, the FasI fatty acid
synthase of the M. tuberculosis complex. FAS was not previ-
ously reported as antigenic, although the amino acid sequence
similarity of Fas to other enzymes involved in lipid synthesis
(Pks and Mas) may contribute to a sort of cross-talk antige-
nicity (15).
The presence of EsxI in the cell extract or culture superna-
tant in low concentrations was confirmed, and the presence of
HspX in the cell extract, as expected, was confirmed. In our
study, EsxI and Rv0138 were the more reactive antigens when
tested in experimentally infected animals, according to IFN-
results at an advanced stage of infection. To our knowledge,
this report is the first description of the antigenicity of EsxI and
Rv0138. Among all antigens tested, the strongest reaction was
that directed to CFP-10/ESAT-6, as previously observed (1).
Rv3740, Rv1636, and Rv2524 had low or null antigenicity for
cell-mediated immunity. One may suppose that not all of the
proteins identified by the proteomic approach used in this
study would be antigenic. In some cases, the true antigenic
proteins in a given fraction would not have been identified in
the 2D gels.
Cellular responses toward selected antigens were also tested
in naturally infected animals. Based on the average of the
IFN- responses, HspX discriminates PPD skin test-positive
animals from PPD skin test-negative animals better than EsxI.
FIG. 5. Results of study of recombinant antigens by IFN- whole-
blood-based assay in TST-positive (F; n  79) and -negative (neg [E];
n  22) animals. Results are expressed as the scatter plot of the ODIs.
ODIs (points) and means (horizontal bars) for infected animals are
shown. According to the recommendations of the Office des Interna-
tional Epizooties, in Argentina, the cutoff point for positivity of the
TST is 
5 mm (skin thickness), for suspected infection is 3 to 5 mm,
and for negativity is 	3 mm. Error bars show standard deviations.
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HspX was described as a latency-associated protein. The time
when these animals were infected is unknown, but we could
assume that they were in an advanced stage of infection. To
our knowledge, this is the first report about the antigenic
potential of HspX in bovine TB. It could be assumed that
HspX detects animals not identified by testing based on EsxI.
In this case, the two proteins should be complementary as
diagnostic antigens. Different antigen responses could show up
in naturally and experimentally infected animals. This could be
due to the differential virulence of the strains or to the stage of
bovine TB infection in different animals.
In summary, we report novel antigens of Mycobacterium
bovis, shown to react in IFN- assays in naturally and experi-
mentally infected animals. Antigen-specific T-cell and IFN-
responses to a panel of mycobacterial fractions were assessed
at regular intervals throughout the infection period. Among
the antigens identified here, HspX, EsxI, and Rv0138 were
shown to be promising antigens for diagnosis, and even if the
sensitivities and specificities of tests based on these antigens
are not optimal, they may form part of a combination or
cocktail for the diagnosis of bovine TB.
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